Strong revenue growth fails to shield India Inc margins in March quarter

Corporate India posted robust revenue increases during the March 2026 quarter. However, rising input costs and a weaker rupee pressured operating margins across many companies.

Sectors such as automobiles and banking recorded solid growth. In contrast, cement and oil companies encountered notable difficulties amid the same period.

Makala yanayohusiana

Realistic illustration showing India's economic growth with cityscape and financial symbols amid global challenges.
Picha iliyoundwa na AI

India's economy grows 7.7 per cent in 2025-26 amid global shocks

Imeripotiwa na AI Picha iliyoundwa na AI

Provisional GDP estimates released on Friday show 7.7 per cent growth for 2025-26. The figure exceeds the government's February prediction by 0.1 percentage points. Outlook for 2026-27 points to a slowdown.

Nifty 50 firms expect double-digit revenue growth for the June 2026 quarter but project only single-digit profit increases due to rising costs. Input cost inflation and higher crude prices are squeezing margins across sectors.

Imeripotiwa na AI

India's listed brokers and exchanges posted strong results for the March quarter. Growth came from higher margin trading and increased market activity.

Gokaldas Exports achieved strong sequential growth in both revenue and profit for the March quarter. The company posted a 9% rise in revenue despite ongoing global trade disruptions and US tariff pressures.

Imeripotiwa na AI

Tata Consultancy Services posted flat dollar revenue for the June quarter along with margin contraction. AI revenue grew but stayed a small share of total earnings. The company also paid out large dividends.

Nine BSE smallcap companies delivered standout performances in the March 2026 quarter, with net profits surging over 50% year-on-year and share prices rising 50% to 170% in the past year. Four of these stocks became multibaggers, more than doubling investor returns. Data from ACE Equity highlights the momentum amid mixed results from 168 reporting firms.

Imeripotiwa na AI

Indian pharmaceutical companies Dr Reddy's and Cipla reported weaker results for the June quarter due to falling profits in the US market. Their domestic operations performed better and provided some offset. Analysts lowered earnings estimates for future years as a result.

Jumatatu, 27. Mwezi wa saba 2026, 13:24:14

Broker earnings stay under pressure in Q1 as derivatives trading slows

Jumapili, 19. Mwezi wa saba 2026, 04:35:29

Q1 earnings show double-digit growth for Indian firms

Jumatano, 8. Mwezi wa saba 2026, 18:46:53

TCS anticipates slower growth in June 2026 quarter

Jumatano, 24. Mwezi wa sita 2026, 01:25:47

Largecaps lead profit growth in March 2026 quarter

Ijumaa, 5. Mwezi wa sita 2026, 17:38:56

India posts 7.8 percent GDP growth in March quarter

Jumamosi, 30. Mwezi wa tano 2026, 15:21:16

Jupiter Wagons reports sharp drop in March quarter profit

Alhamisi, 28. Mwezi wa tano 2026, 05:18:46

Top Indian investors see portfolio declines in March quarter

Jumapili, 24. Mwezi wa tano 2026, 11:37:04

Sun Pharma reports strong quarterly growth but eyes margin pressure

Alhamisi, 21. Mwezi wa tano 2026, 06:13:52

Cigarette business weakness drags ITC margins in March quarter

Ijumaa, 8. Mwezi wa tano 2026, 12:06:56

Mcx reports 291 percent surge in q4 net profit

 

 

 

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa